# Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels

> **NCT00671307** · PHASE1,PHASE2 · COMPLETED · sponsor: **Critical Biologics Corporation** · enrollment: 40 (estimated)

## Conditions studied

- Low Gelsolin
- Trauma
- Infection
- Burns

## Interventions

- **DRUG:** rhu-pGelsolin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00671307
- **Lead sponsor:** Critical Biologics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00671307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00671307, "Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00671307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*